No Hotter Health Care Issue Than Drug Pricing, Lobbyist Says - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Top Stories
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Health/Employee Benefits News
Top Stories RSS Get our newsletter
Order Prints
February 23, 2021 Top Stories
Share
Share
Post
Email

No Hotter Health Care Issue Than Drug Pricing, Lobbyist Says

By Susan Rupe

There is no health care issue hotter than drug pricing, Jonathon Jones told members of the National Association of Health Underwriters at their virtual Capitol Conference. Jones is a partner with the government relations consultant Peck Madigan Jones.

“It’s not just a Democratic priority – it has become a priority for both parties,” Jones said in looking ahead to what the Biden administration and the new Congress mean for health care.

Of the major health care issues in Washington, lowering the cost of prescription drugs is the issue that enjoys the most bipartisan support, at least ideologically, Jones said. “Everyone agrees on the idea that we need to do something to change the U.S. laws to reduce drug prices.”

In December 2019, the House of Representatives passed H.R.3, the Elijah E. Cummings Lower Drug Costs Now Act, but the bill did not come up for a Senate vote. Jones said he did not believe H.R. 3 will come up in the House again this year.

“I definitely don’t think it will become law,” he said. “I think with drug pricing, one of two things will happen. One is that in the Senate, if there is an outreach to Democrats from Republicans, there’s a growing recognition that the Senate could pass a bipartisan drug pricing bill. For the Biden administration, it could open an opportunity to do a big piece of health legislation with bipartisan support.

“The other option is that because a lot of the drug pricing policies generate revenue for the federal government, they could be paired with further expansions of the Affordable Care Act like we saw in this current COVID-19 relief package.”

What about the chances of Medicare for All or a public option becoming law anytime soon? Jones had some thoughts.

“President Biden wasn’t only unsupportive of Medicare for All but he campaigned against it and advocated building on the ACA instead. I think he has taken steps in this first COVID-19 bill to make good on that promise. The bill has a number of provisions that strengthen the current ACA system. I think he will continue to steer down that path. But the left wing of the Democratic party will continue to push for M4A and for public option.”

Jones said he believes “it’s virtually impossible that Medicare for All would pass” in Biden’s first two years in office. But a public option is a more likely possibility.

“I think it depends on what you consider to be a public option,” he said. “You could see some things that would quality as a modest public option, such as reducing the eligibility age for Medicare. There’s strong support in the Democratic party for a Medicare buy-in or public option. But I think it will be much more of a modest step and not a robust public option available to a really broad group of people.”

In health care, “you’re always straddling between the idea of adding something new and taking away something popular,” Jones said. “Republicans ran into this when they tried to repeal the ACA unsuccessfully in 2017. And I think Democrats are facing the same situation and they will go slow on this.”

Jones predicted that the nation “will continue to take more incremental steps toward government health care.”

“I’m not saying we will go to a single-payer system. But I think government will be more involved and public options will be available for more people.”

Jones cautioned that government policies eventually will take more people away from the employer-sponsored health care model.

“What I worry about is over time and as the ACA plans get bigger and we allow more people to participate, we’ll take more people out of employer market. It will reach a point where it becomes harder to defend the system. We need to have more affordable options so we can compete with this idea that the government can give people everything they want without their having to pay for it. The ability of this industry to provide choices is critical.”

Susan Rupe is managing editor for InsuranceNewsNet. She formerly served as communications director for an insurance agents' association and was an award-winning newspaper reporter and editor. Contact her at Susan.Rupe@innfeedback.com. Follow her on Twitter @INNsusan.

© Entire contents copyright 2021 by InsuranceNewsNet.com Inc. All rights reserved. No part of this article may be reprinted without the expressed written consent from InsuranceNewsNet.com.

Susan Rupe

Susan Rupe is editor in chief, magazine, for InsuranceNewsNet. She formerly served as communications director for an insurance agents' association and was an award-winning newspaper reporter and editor. Contact her at susan.rupe@innfeedback.com.

Older

Public Option Would Be Destabilizing, NAHU Exec Says At CapCon

Newer

Wealthspire Advisors Rolls Out Impact And ESG-Based Investment Portfolios

Advisor News

  • Flourish brings private-bank-like cash solution to MassMutual’s network
  • Majority of Americans concerned recent market highs are unsustainable
  • GLP-1 users choose between medication and retirement saving
  • Gen X and millennials seek new retirement model
  • Are families ready for the costs of aging at home?
More Advisor News

Annuity News

  • Insurer proposes $1.1M deal to resolve CA teachers’ annuity fee lawsuit
  • IMOs get frustrated with slow carrier adoption of faster technology
  • New class-action lawsuit targets Delaware Life over annuity disclosures
  • A client remarried: Does their annuity still fit?
  • Gen X and millennials seek new retirement model
More Annuity News

Health/Employee Benefits News

  • SMH, UnitedHealthcare wrangle over coverage
  • Millions lose private Medicare plans and face rising costs
  • State announces rates for 2027 small group health insurance market
  • Rethinking the status quo can lead to long-term savings on healthcare
  • NABIP urges Congress to address underlying healthcare costs
Sponsor
More Health/Employee Benefits News

Life Insurance News

  • BILTIR conference draws more than 750 insurance leaders to Bermuda
  • Death and taxes: How the right analysis for life insurance changes the picture
  • Life insurance applications rise 15.2% in September, MIB reports
  • Flourish brings private-bank-like cash solution to MassMutual’s network
  • What ‘above and beyond’ means for today’s advisor
Sponsor
More Life Insurance News

- Presented By -

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Press Releases

  • Lauren Sinnott Named to Ragan’s Top Women in Marketing Awards, Class of 2026 
  • Classic Car Insurer OpenRoad Insurance Expands to 40 U.S. States in Two Years
  • How Aspire General Turned an Early Technology Bet Into Claims Automation at Scale with Kyber
  • Adjusto launches AI-Native contents claims services powered by its technology platform
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.